Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.47 USD | -1.40% | -6.92% | +162.23% |
04-10 | Arcutis Biotherapeutics, Inc. Announces Chief Financial Officer Changes | CI |
03-18 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index | CI |
Sales 2024 * | 117M 160M | Sales 2025 * | 236M 322M | Capitalization | 978M 1.34B |
---|---|---|---|---|---|
Net income 2024 * | -227M -310M | Net income 2025 * | -144M -197M | EV / Sales 2024 * | 6.38 x |
Net cash position 2024 * | 231M 316M | Net cash position 2025 * | 228M 312M | EV / Sales 2025 * | 3.18 x |
P/E ratio 2024 * |
-3.84
x | P/E ratio 2025 * |
-6.36
x | Employees | 296 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.5% |
Latest transcript on Arcutis Biotherapeutics, Inc.
1 day | -1.40% | ||
1 week | -6.92% | ||
Current month | -14.53% | ||
1 month | -11.68% | ||
3 months | +59.81% | ||
6 months | +262.74% | ||
Current year | +162.23% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 55 | 15-12-31 |
Rajvir Madan
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-31 |
Jay Ramsinghani
COO | Chief Operating Officer | - | 20-05-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Heron
CHM | Chairman | 53 | 16-03-31 |
Founder | 69 | 16-05-31 | |
Keith Leonard
BRD | Director/Board Member | 62 | 21-09-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 8.47 | -1.40% | 2,164,430 |
24-04-25 | 8.59 | -1.83% | 2,251,981 |
24-04-24 | 8.75 | +0.11% | 2,001,981 |
24-04-23 | 8.74 | -2.24% | 1,595,733 |
24-04-22 | 8.94 | -1.76% | 1,227,500 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+162.23% | 974M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ARQT Stock